IBDEI0JA ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25933,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,25933,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,25933,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,25934,0)
 ;;=250.01^^165^1540^21
 ;;^UTILITY(U,$J,358.3,25934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25934,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,25934,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,25934,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,25935,0)
 ;;=V08.^^165^1540^40
 ;;^UTILITY(U,$J,358.3,25935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25935,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,25935,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,25935,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,25936,0)
 ;;=921.0^^165^1540^16
 ;;^UTILITY(U,$J,358.3,25936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25936,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,25936,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,25936,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,25937,0)
 ;;=379.91^^165^1540^86
 ;;^UTILITY(U,$J,358.3,25937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25937,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,25937,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,25937,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,25938,0)
 ;;=V58.69^^165^1540^44
 ;;^UTILITY(U,$J,358.3,25938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25938,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,25938,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,25938,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,25939,0)
 ;;=871.4^^165^1540^54
 ;;^UTILITY(U,$J,358.3,25939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25939,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,25939,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,25939,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,25940,0)
 ;;=242.90^^165^1540^107
 ;;^UTILITY(U,$J,358.3,25940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25940,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,25940,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,25940,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,25941,0)
 ;;=135.^^165^1540^100
 ;;^UTILITY(U,$J,358.3,25941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25941,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,25941,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,25941,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,25942,0)
 ;;=446.5^^165^1540^106
 ;;^UTILITY(U,$J,358.3,25942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25942,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,25942,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,25942,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,25943,0)
 ;;=401.9^^165^1540^49
 ;;^UTILITY(U,$J,358.3,25943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25943,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,25943,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,25943,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,25944,0)
 ;;=V72.0^^165^1540^32
 ;;^UTILITY(U,$J,358.3,25944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25944,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,25944,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,25944,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,25945,0)
 ;;=V41.0^^165^1540^90
 ;;^UTILITY(U,$J,358.3,25945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25945,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,25945,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,25945,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,25946,0)
 ;;=998.59^^165^1540^88
 ;;^UTILITY(U,$J,358.3,25946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25946,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,25946,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,25946,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,25947,0)
 ;;=042.^^165^1540^1
 ;;^UTILITY(U,$J,358.3,25947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25947,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,25947,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,25947,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,25948,0)
 ;;=053.29^^165^1540^43
 ;;^UTILITY(U,$J,358.3,25948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25948,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,25948,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,25948,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,25949,0)
 ;;=054.40^^165^1540^42
 ;;^UTILITY(U,$J,358.3,25949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25949,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,25949,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,25949,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,25950,0)
 ;;=190.1^^165^1540^82
 ;;^UTILITY(U,$J,358.3,25950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25950,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,25950,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,25950,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,25951,0)
 ;;=190.2^^165^1540^50
 ;;^UTILITY(U,$J,358.3,25951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25951,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,25951,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,25951,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,25952,0)
 ;;=190.7^^165^1540^52
 ;;^UTILITY(U,$J,358.3,25952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25952,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,25952,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,25952,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,25953,0)
 ;;=202.81^^165^1540^61
 ;;^UTILITY(U,$J,358.3,25953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25953,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,25953,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,25953,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,25954,0)
 ;;=215.9^^165^1540^84
 ;;^UTILITY(U,$J,358.3,25954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25954,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,25954,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,25954,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,25955,0)
 ;;=224.2^^165^1540^51
 ;;^UTILITY(U,$J,358.3,25955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25955,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,25955,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,25955,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,25956,0)
 ;;=224.5^^165^1540^95
 ;;^UTILITY(U,$J,358.3,25956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25956,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,25956,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,25956,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,25957,0)
 ;;=224.7^^165^1540^28
 ;;^UTILITY(U,$J,358.3,25957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25957,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,25957,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,25957,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,25958,0)
 ;;=237.70^^165^1540^66
 ;;^UTILITY(U,$J,358.3,25958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25958,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,25958,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,25958,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,25959,0)
 ;;=239.6^^165^1540^65
 ;;^UTILITY(U,$J,358.3,25959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25959,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,25959,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,25959,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,25960,0)
 ;;=239.81^^165^1540^96
 ;;^UTILITY(U,$J,358.3,25960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25960,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,25960,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,25960,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,25961,0)
 ;;=272.0^^165^1540^48
 ;;^UTILITY(U,$J,358.3,25961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25961,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,25961,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,25961,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,25962,0)
 ;;=340.^^165^1540^63
 ;;^UTILITY(U,$J,358.3,25962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25962,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,25962,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,25962,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,25963,0)
 ;;=345.90^^165^1540^29
 ;;^UTILITY(U,$J,358.3,25963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25963,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,25963,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,25963,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,25964,0)
 ;;=368.02^^165^1540^23
 ;;^UTILITY(U,$J,358.3,25964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25964,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,25964,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,25964,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,25965,0)
 ;;=368.11^^165^1540^102
 ;;^UTILITY(U,$J,358.3,25965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25965,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,25965,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,25965,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,25966,0)
 ;;=368.59^^165^1540^11
 ;;^UTILITY(U,$J,358.3,25966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25966,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,25966,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,25966,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,25967,0)
 ;;=368.60^^165^1540^67
 ;;^UTILITY(U,$J,358.3,25967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25967,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,25967,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,25967,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,25968,0)
 ;;=368.9^^165^1540^113
 ;;^UTILITY(U,$J,358.3,25968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25968,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25968,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,25968,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,25969,0)
 ;;=369.00^^165^1540^108
 ;;^UTILITY(U,$J,358.3,25969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25969,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,25969,1,4,0)
 ;;=4^369.00
